We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Dermal Thermometry Helps Diabetics Keep Their Feet

By HospiMedica staff writers
Posted on 25 Dec 2007
Skin temperature monitoring significantly reduces foot ulcers in diabetics who suffer neuropathy (numbness in their extremities), according to a new study. More...


Researchers at Rosalind Franklin University (Chicago, IL, USA) conducted a physician-blinded, 18-month randomized controlled trial of 225 subjects with diabetes at high risk for ulceration. The patients were assigned to standard therapy or dermal thermometry groups. Both groups received therapeutic footwear, diabetic foot education, regular foot care, and performed a structured foot inspection daily. Dermal thermometry group subjects used an infrared skin thermometer--called TempTouch--to measure temperatures on six foot sites twice daily. Temperature differences of more than four degrees Farenheit between left and right corresponding sites triggered patients to contact the study nurse and reduce activity until temperatures normalized.

The researchers found that a total of 8.4% of the subjects ulcerated over the study period. Subjects were one third as likely to ulcerate in the dermal thermometry group compared with the standard therapy group. Proportional hazards regression analysis suggested that thermometry intervention was associated with a significantly longer time to ulceration, adjusted for elevated foot ulcer classification, age, and minority status. Patients that ulcerated had a temperature difference that was 4.8 times greater at the site of ulceration in the week before ulceration than did a random 7 consecutive-day sample of 50 other subjects that did not ulcerate. The study was published in the December 2007 issue of the American Journal of Medicine.

"A wound will heat up before the skin breaks down,” said lead author Dr. David Armstrong, a professor of surgery and director of the Scholl College Center for Lower Extremity Ambulatory Research (CLEAR) at Rosalind Franklin University. "You can detect infection by checking one foot compared to another foot, one toe compared to another toe.”

The infrared TempTouch, manufactured by Xilas Medical (San Antonio, TX, USA) is a wand-like, gooseneck thermometer that diabetics use before they begin their day's activities. A spike in temperature warns that an infection is brewing so they can stay off their feet until the threat of an ulcer subsides.


Related Links:
Rosalind Franklin University
Xilas Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.